COVID-19 infection may increase the risk of parkinsonism – Remember the Spanish flu?

Mohamed Eldeeb is Canadian Institute of Health Research (CIHR) Banting Fellow. He has earned his PhD from the University of Alberta focusing on the N-end rule mediated protein degradation of kinases in cancer cells and its cellular ramifications on cancer cell death. He has joined the Montreal Neurological Institute to investigate the molecular mechanisms underlying neurodegeneration. He is applying structural biology and molecular tools to understand the molecular culprits underlying Parkinson’s disease. He has been supported by Parkinson Canada.

Faraz Hussain has earned his Ph.D. focusing on molecular genomics and infectious disease from the University of Karachi, Pakistan. He received his postdoctoral training at the neurology division, University of Alberta, under the supervision of Prof. Zaeem Siddiqi and Prof. Richard Fahlman. He is continuing his research at the Neurology division with a focus on neuromuscular, autoimmune disorders and omics.

Zaeem Siddiqi received his medical training from Army Medical College, Rawalpindi, Pakistan and earned a Ph.D. in Neurobiology from Boston University School of Medicine. He completed his residency in Adult Neurology and a fellowship in Clinical Neurophysiology at Duke University Medical Center. Currently, he is a professor of Neurology and Director of the neuromuscular program at the University of Alberta. He is involved in clinical and translational research in autonomic and neuromuscular disorders.